Possible Sites of Therapeutic Action in Restless Legs Syndrome: Focus on Dopamine and α2δ Ligands

Publisher： Karger

E-ISSN： 1421-9913|66|1|18-29

ISSN： 0014-3022

Source： European Neurology, Vol.66, Iss.1, 2011-06, pp. : 18-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zolpidem in Restless Legs Syndrome

By  

European Neurology, Vol. 48, Iss. 3, 2002-10 ,pp. : 180-181

Karger

Access to resources Recommend Favorite

Restless Legs Syndrome in Multiple Sclerosis

By  

European Neurology, Vol. 65, Iss. 5, 2011-05 ,pp. : 302-306

Karger

Access to resources Recommend Favorite

Parkinson's Disease and Restless Legs Syndrome

By  

European Neurology, Vol. 73, Iss. 3-4, 2015-0 ,pp. : 212-219

Karger

Access to resources Recommend Favorite

Celiac Disease Is Associated with Restless Legs Syndrome

By Weinstock Leonard   Walters Arthur   Mullin Gerard   Duntley Stephen  

Digestive Diseases and Sciences, Vol. 55, Iss. 6, 2010-06 ,pp. : 1667-1673

Springer Publishing Company

Access to resources Recommend Favorite

Restless Legs Syndrome in Hereditary Spastic Paraparesis

By  

European Neurology, Vol. 57, Iss. 1, 2006-11 ,pp. : 31-35

Karger

Access to resources Recommend Favorite